Ivermectin B1a-D2

CAS : 71827-03-7

Ref. 3D-WCA82703

Informations sur le produit

• Nom: Ivermectin B1a-D2
• Synonymes: (2aE,4E,5'S,6S,6'R,8E,11R,13R,15S,17aR,20R,20aR,20bS)-20,20b-dihydroxy-5',6,8,19-tetramethyl-6'-[(1S)-1-methylpropyl]-17-oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-7-yl (4xi)-2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranosyl)-3-O-methyl-α-L-threo-hexopyranoside, 22,23-Dihydro-5-O-demethylavermectin A1a, 22,23-Dihydroavermectin B(1)a, 22,23-Dihydroavermectin B1a, 22,23-Dihydroavermectin B_1a, 5-O-Demethyl-22,23-dihydroavermectin A_1a, Avermectin A1a, 22,23-dihydro-5-O-demethyl-, Avermectin A_1a, 5-O-demethyl-22,23-dihydro-, Brn 4643153, Dihydroavermectin B1a, Dihydroavermectin B_1a, Ivermectin B1a, Ivermectin B_1a, Spiro[11,15-methano-2H,13H,17H-furo[4,3,2-pq][2,6]benzodioxacyclooctadecin-13,2′-[2H]pyran], avermectin A_1a deriv., Unii-91Y2202Ouw
• CAS: 71827-03-7

Description

Ivermectin is a broad-spectrum antiparasitic agent that is used to treat onchocerciasis and other infectious diseases. It binds selectively to gamma-aminobutyric acid (GABA) receptors in the central nervous system and inhibits the release of neurotransmitters, thereby inhibiting the inflammatory response. Ivermectin has been shown to be safe for use in humans and has a long half-life that allows for once-weekly administration. This drug also has pharmacokinetic properties that are similar among different species and clinical studies have shown no significant differences between human and animal models. Ivermectin is applied topically as an ointment or cream or orally as tablets or capsules, depending on the condition being treated.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 877.11 g/mol
• Formule: C₄₈H₇₂D₂O₁₄
• Degré de pureté: Min. 95%